Effect of 90 Days Sub-chronic Administration of Omeprazole (A Proton Pump Inhibitor) on Haematological, Biochemical, Antioxidant, Reproductive and Histopathological Parameters in Male and Female Rats

Abbas, M.K., Zaidi, A.R.Z., Robert, C.A., Thiha, S., and Malik, B.H. (2019). The safety of long-term daily usage of a proton pump inhibitor: A literature review.Cureus, 11(9): e5563. https://doi.org/10.7759/cureus.5563 Search in Google Scholar

Afolabi, S.O., Akindele, A.J., Awodele, O., Anunobi, C.C., and Adeyemi, O.O. (2012). A 90 day chronic toxicity study of Nigerian herbal preparation DAS-77 in rats. BMC Complementary and Alternative Medicine, 12: 1-18. DOI: 10.1186/1472-6882-12-79 Search in Google Scholar

Ali, T., Roberts, D.N., and Tierney, W.M. (2009). Long-term safety concerns with proton pump inhibitors. American Journal of Medicine, 10: 896-903. DOI: 10.1016/j.amjmed.2009.04.014 Search in Google Scholar

Al-Sayed, E., and El-Naga, R. N. (2015). Protective role of ellagitannins from Eucalyptus citriodora against ethanol-induced gastric ulcer in rats: impact on oxidative stress, inflammation and calcitonin-gene related peptide. Phytomedicine, 22: 5-15. DOI: 10.1016/j.phymed.2014.10.002 Search in Google Scholar

Amida, M.B., Yemitan, O.K., and Adeyemi, O.O. (2007). Toxicological assessment of the aqueous root extract of Sansevieraliberica Gerome and Labroy (Agavaceae). Journal of Ethnopharmacolo gy, 113(1):171-175. DOI: 10.1016/j.jep.2007.03.033 Search in Google Scholar

Arnold, R., and Koop, H. (1989). Omeprazole: Long-term safety. Digestion, 44: 77-86. DOI: 10.1159/000200107 Search in Google Scholar

Attwood, S.E., Ell, C., Galmiche, J.P., Fiocca, R., Hatlebakk, J.G., Hasselgren, B., Langstrom, G., Jahreskog, M., Eklund, S., Lind, T., and Lundell, L. (2015). Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: Data from the SOPRAN and LOTUS studies. Alimentary Pharmacology and Therapeutics, 41(11): 1162-1174. DOI: 10.1111/apt.13194 Search in Google Scholar

Banihani, S.A. (2016). Omeprazole and semen quality. Basic and Clinical Pharmacology and Toxicology, 118(3): 181-183. DOI: 10.1111/bcpt.12529 Search in Google Scholar

Bate, C.M., Riley, S.A., Chapman, R.W.G., Durnin, A.T., and Taylor, M.D. (1999). Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics,13(1):59-66. DOI: 10.1046/j.1365-2036.1999.00429.x Search in Google Scholar

Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., and Banerjee, R.K. (2003). A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. Journal of Biological Chemistry, 278(13): 10993-11001. DOI: 10.1074/jbc.M210328200 Search in Google Scholar

Braga, A.L., de Meneses, A.A.P.M., Santos, J.V. de O., dos Reis, A.C., de Lima, R.M.T., da Mata, A.M.O.F., Paz, M.F.C.J., Alves, L.B. dos S., Shaw, S., Uddin, S.J., Rouf, R., Das, A.K., Dev, S., Shil, M.C., Shilpi, J.A., Khan, I.N., Islam, M.T., Ali, E.S., Mubarak, M.S., Mishra, S.K., e Sousa, J.M. de C., and Melo-Cavalcante, A.A. de C. (2018). Toxicogenetic study of omeprazole and the modulatory effects of retinol palmitate and ascorbic acid on Allium cepa. Chemosphere, 204:220-226. DOI: 10.1016/j.chemosphere.2018.04.021 Search in Google Scholar

Braga, A.L., do Nascimento, P.B., Paz, M.F.C.J., de Lima, R.M.T., Santos, J.V. de O., de Alencar, M.V.O.B., de Meneses, A.A.P.M., Júnior, A.L.G., Islam, M.T., Sousa, J.M. de C. e., and Melo-Cavalcante, A.A. de C. (2021). Antioxidative defense against omeprazole-induced toxicogenetical effects in Swiss mice. Pharmacological Reports, 73: 551-562. DOI: 10.1007/s43440-021-00219-1 Search in Google Scholar

Cheesbrough, M. (2005). District laboratory practice in tropical countries, District Laboratory Practice in Tropical Countries. https://doi.org/10.1017/CBO9780511581304 Search in Google Scholar

Chen, W.C., Li, Y. da, Chiang, P.H., Tsay, F.W., Chan, H.H., Tsai, W.L., Tsai, T.J., Wang, E.M., Cheng, J.S., and Lai, K.H. (2014). Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: A retrospective cohort study. BioMed Research International, 2014:693567. https://doi.org/10.1155/2014/693567 Search in Google Scholar

Downes, N., and Foster, J. (2015). Regulatory forum opinion piece: Carcinogen risk assessment: The move from screens to science. Toxicologic Pathology, 43(8):1064-1073. DOI: 10.1177/0192623315598578 Search in Google Scholar

Elmahdy, Marwa F., and Almater, Jadees M. (2019). Omeprazole induced increase in liver markers-A case report. Journal of Clinical & Diagnostic Research, 13(10): 1-2. DOI: 10.7860/JCDR/2019/41848.13218 Search in Google Scholar

Ertenli, I., Kiraz, S., Öztürk, M.A., Haznedaroǧlu, I.C., Çelik, I., and Çalgüneri, M. (2003). Pathologic thrombopoiesis of rheumatoid arthritis. Rheumatology International, 23: 49-60. DOI: 10.1007/s00296-003-0289-0 Search in Google Scholar

Fass, R., Ofman, J.J., Gralnek, I.M., Johnson, C., Camargo, E., Sampliner, R.E., and Fennerty, M.B. (1999). Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Archives of Internal Medicine,159(18): 2161-2168. DOI: 10.1001/archinte.159.18.2161 Search in Google Scholar

Fatima, S., Sheikh, N., and Tayyeb, A. (2019). Investigation of hepatic and renal toxicity induced by omeprazole in CCl₄ injury mouse model. Zeitschrift für Gastroenterologie, 57(01): e12. DOI: 10.1055/s-0038-1677070 Search in Google Scholar

Forgacs, I., and Loganayagam, A. (2008). Overprescribing proton pump inhibitors. BMJ,336:2. https://doi.org/10.1136/bmj.39406.449456.BE Search in Google Scholar

Forgerini, M., Mieli, S., and Mastroianni, P. de C. (2018). Safety assessment of omeprazole use: A review. Sao Paulo Medical Journal, 136(06):557-570.DOI: 10.1590/1516-3180.2018.0019220318 Search in Google Scholar

Ganguly, K., Kundu, P., Banerjee, A., Reiter, R.J, and Swarnakar, S. (2006). Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radical Biology and Medicine, 41: 911-925. DOI: 10.1016/j.freeradbiomed.2006.04.022 Search in Google Scholar

Giannakeas, V., Narod, S.A. (2021). Incidence of cancer among adults with thrombocytosis in Ontario, Canada. JAMA Network Open, 4(8): e2120633. https://doi.org/10.1001/jamanetworkopen.2021.20633 Search in Google Scholar

Guduru, J., and Singh, T.R. (2016). Evaluation of genotoxicity of gastric proton pump inhibitor omeprazole and role of vitamin-E in mice. The Pharma Innovation Journal, 5: 66-71. https://www.thepharmajournal.com/archives/2016/vol5issue8/PartB/5-7-25-804.pdf Search in Google Scholar

Heidelbaugh, J.J., Kim, A.H., and Walker, P.C. (2012). Overutilization of proton-pump inhibitors: What the clinician needs to know. Therapeutic Advances in Gastroenterology, 5(4): 219-232. DOI: 10.1177/1756283X12437358 Search in Google Scholar

Herbet, M., Izdebska, M., Piątkowska-Chmiel, I., Poleszak, E., and Jagiełło-Wójtowicz, E. (2016). Estimation of oxidative stress parameters in rats after simultaneous administration of rosuvastatin with antidepressants. Pharmacological Reports, 68(1): 172-176. DOI: 10.1016/j.pharep.2015.08.004 Search in Google Scholar

Hess, M.W., Hoenderop, J.G.J., Bindels, R.J.M., and Drenth, J.P.H. (2012). Systematic review: Hypomagnesaemia induced by proton pump inhibition. Alimentary Pharmacology and Therapeutics, 36(5): 405-413. DOI: 10.1111/j.1365-2036.2012.05201.x Search in Google Scholar

Ishola, I.O., Akindele, A.J., and Adeyemi, O.O. (2012). Sub-chronic toxicity study of the methanol root extract of Cnestisferruginea. Pharmaceutical Biology, 50: 994-1006. DOI: 10.3109/13880209.2012.655376 Search in Google Scholar

Jassim, S.Y., and Nasser, R.A.A. (2018). Effect of omeprazole on liver functions of laboratory rat (albino) Rattus norvegicus. International Journal of Biosciences, 12(6): 123-128. DOI: http://dx.doi.org/10.12692/ijb/12.6.123-128 Search in Google Scholar

Joelson, S., Joelson, I.B., Lundborg, P., Walan, A., and Wallander, M.A. (1992). Safety experience from long-term treatment with omeprazole. Digestion, 51(Suppl 1): 93-101. DOI: 10.1159/000200922 Search in Google Scholar

Kalra, A., Yetisku, E., Wehrle, C.J., and Tuma, F. (2018). Physiology, Liver, StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK535438/ Search in Google Scholar

Kiguba, R., Olsson, S., and Waitt, C. (2023). Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa. British Journal of Clinical Pharmacology, 89(2): 491-509. DOI: 10.1111/bcp.15193 Search in Google Scholar

Koch, T.R., Yuan, L.X, Petro, A., and Opara, E.C. (2002). Effects of omeprazole and ascorbate on gastric emptying and antioxidant levels in a mouse model of glutathione depletion. Digestive Diseases and Sciences, 47: 2486-2492. DOI: 10.1023/a:1020555925142 Search in Google Scholar

Kucuk H.F., Akyol H., Kaptanoglu L., Kurt N., Barisik N.O., Bingul S., Torlak O.A., and Colak E. (2006). Effect of proton pump inhibitors on hepatic regeneration. European Surgical Research, 38:322-328. DOI: 10.1159/000094020 Search in Google Scholar

Laheij, R.J.F., Sturkenboom, M.C.J.M., Hassing, R.J., Dieleman, J., Stricker, B.H.C., and Jansen, J.B.M.J. (2004). Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA, 292(16): 1955-1960. DOI: 10.1001/jama.292.16.1955 Search in Google Scholar

Li, W., Zeng, S., Yu, L.S., and Zhou, Q. (2013). Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management. Therapeutics and Clinical Risk Management, 9: 259-271. DOI: 10.2147/TCRM.S43151 Search in Google Scholar

Lundell, L. (2015). The physiological background behind and course of development of the first proton pump inhibitor. Scandinavian Journal of Gastroenterology, 50(6): 680-684. DOI: 10.3109/00365521.2015.1013981 Search in Google Scholar

Mastroianni, P.D.C., Varallo, F.R., Barg, M.S., Noto, A.R., and Galduroz, J.C.F. (2009). Contribution of the use of drugs for hospital admission. [Portuguese] Contribuicao do uso de medicamentos para aadmissaohospitalar. Brazilian Journal of Pharmaceutical Sciences, 45(1): 163-170. DOI10.1590/s1984-82502009000100020 Search in Google Scholar

Moayyedi, P., and Leontiadis, G.I. (2012). The risks of PPI therapy. Nature Reviews Gastroenterology & Hepatology, 9: 132-139. https://doi.org/10.1038/nrgastro.2011.272 Search in Google Scholar

National Academy of Sciences (2011). Guide for the Care and Use of Laboratory Animals, 8th edition. ed. National Academies Press, Washington DC. doi: 10.17226/12910 Search in Google Scholar

Neumann, H.G. (2009). Risk assessment of chemical carcinogens and thresholds. Critical Reviews in Toxicology, 39(6): 449-461. DOI: 10.1080/10408440902810329 Search in Google Scholar

Ogli, S.A., Enyikwola, O., and Odeh, S.O. (2009). Evaluation of the efficacy of separate oral supplements compared with the combined oral supplements of vitamins C and E on sperm motility in Wistar rats. Nigerian Journal of Physiological Sciences, 24: 129-135. DOI: 10.4314/njps.v24i2.52931 Search in Google Scholar

Olbe, L., Carlsson, E., and Lindberg, P. (2003). A proton-pump inhibitor expedition: The case histories of omeprazole and esomeprazole. Nature Reviews Drug Discovery, 2: 132-139. DOI: 10.1038/nrd1010 Search in Google Scholar

Paz, M.F.C.J., de Alencar, M.V.O.B., de Lima, R.M.I.P., Sobral, A.L.P., do Nascimento, G.T.M., dos Reis, C.A., Coêlho, M.D.P.S.D.S., do Nascimento, M.L.L.B., Gomes Júnior, A.L., MacHado, K.D.C., de Menezes, A.A.P.M., de Lima, R.M.T., de Oliveira Filho, J.W.G., Dias, A.C.S., dos Reis, A.C., da Mata, A.M.O.F., MacHado, S.A., Sousa, C.D.D.C., da Silva, F.C.C., Islam, M.T., de Castro E Sousa, J.M., and Melo Cavalcante, A.A.D.C. (2020). Pharmacological effects and toxicogenetic impacts of omeprazole: Genomic instability and cancer. Oxidative Medicine and Cellular Longevity, 2020: 3457890. https://doi.org/10.1155/2020/3457890 Search in Google Scholar

Raza, M., Al-Shabanah, O.A., El-Hadiyah, T.M., and Al-Majed, A.A. (2002). Effect of prolonged vigabatrin treatment on hematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice. Scientia Pharmaceutica, 70: 135-145. https://doi.org/10.3797/scipharm.aut-02-16 Search in Google Scholar

Reimer, C. (2013). Safety of long-term PPI therapy. Best Practice and Research: Clinical Gastroenterology, 27(3): 443-454. DOI: 10.1016/j.bpg.2013.06.001 Search in Google Scholar

Robinson, A.J., Godfrey, A.L. (2021). Low-risk essential thrombocythemia: A comprehensive review. HemaSphere, 5(2): e521. https://doi.org/10.1097/HS9.0000000000000521 Search in Google Scholar

Rosenkranz, H.S., and Klopman, G. (1991). Omeprazole: An exploration of its reported genotoxicity. Mutagenesis, 6(5): 381-384. DOI: 10.1093/mutage/6.5.381 Search in Google Scholar

Savarino, V., di Mario, F., and Scarpignato, C. (2009). Proton pump inhibitors in GORD. An overview of their pharmacology, efficacy and safety. Pharmacological Research, 59(3): 135-153. DOI: 10.1016/j.phrs.2008.09.016 Search in Google Scholar

Scarpignato, C., Gatta, L., Zullo, A., Blandizzi, C. (2016). Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Medicine, 14: 179. DOI: 10.1186/s12916-016-0718-z Search in Google Scholar

Skoda, R.C. (2009). Thrombocytosis. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. https://doi.org/10.1182/asheducation-2009.1.159 Search in Google Scholar

Song, J.W., Seo, C.S., Kim, T.I., Moon, O.S., Won, Y.S., Son, H.Y., Son, J.K., and Kwon, H.J. (2016). Protective effects of Manassantin A against ethanol-induced gastric injury in rats. Biological & Pharmaceutical Bulletin, 39(2):221-229. DOI: 10.1248/bpb.b15-00642 Search in Google Scholar

Soon, Y.Y., and Tan, B.K.H. (2002). Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Medical Journal, 43: 77-85. http://www.smj.org.sg/sites/default/files/4302/4302a4.pdf Search in Google Scholar

Tan, P.V., Mezui, C., Enow-Orock, G., Njikam, N., Dimo, T., and Bitolog, P. (2008). Teratogenic effects, acute and subchronic toxicity of the leaf aqueous extract of Ocimum suave Wild (Lamiaceae) in rats. Journal of Ethnopharmacology, 115: 232-237. DOI: 10.1016/j.jep.2007.09.022 Search in Google Scholar

Thomson, A.B.R., Sauve, M.D., Kassam, N., and Kamitakahara, H. (2010). Safety of the long-term use of proton pump inhibitors. World Journal of Gastroenterology, 16(19): 2323-2330. DOI: 10.3748/wjg.v16.i19.2323 Search in Google Scholar

Trefts, E., Gannon, M., and Wasserman, D.H. (2017). The liver. Current Biology, 27(21): R1147-R1151. DOI: 10.1016/j.cub.2017.09.019 Search in Google Scholar

United States Food and Drug Administration (2012). Prilosec: Full prescribing information [WWW Document]. US FDA. URL https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s096lbl.pdf (accessed 10.11.21). Search in Google Scholar

United States Food and Drug Administration (2017). FDA drug safety communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs) [WWW Document]. US FDA. URL https://www.fda.gov/drugs/drugsafety-and-availability/fda-drug-safety-communication-clostridium-difficile-associated-diarrhea-can-be-associated-stomach (accessed 10.10.21). Search in Google Scholar

Vidya, G., Gladwin, V., and Chand, P. (2015). A comprehensive review on clinical applications of comet assay. Journal of Clinical and Diagnostic Research, 9(3):GE01-GE05. DOI: 10.7860/JCDR/2015/12062.5622 Search in Google Scholar

Voutsadakis, I.A. (2014). Thrombocytosis as a prognostic marker in gastrointestinal cancers. World Journal of Gastrointestinal Oncology, 6(2): 34-40. DOI: 10.4251/wjgo.v6.i2.34 Search in Google Scholar

Weersink, R.A., Bouma, M., Burger, D.M., Drenth, J.P.H., Harkes-Idzinga, S.F., Hunfeld, N.G.M., Metselaar, H.J., Monster-Simons, M.H., van Putten, S.A.W., Taxis, K., and Borgsteede, S.D. (2018). Safe use of proton pump inhibitors in patients with cirrhosis. British Journal of Clinical Pharmacology, 84(8): 1806-1820. DOI: 10.1111/bcp.13615 Search in Google Scholar

Yemitan, O., and Adeyemi, O. (2004). Toxicity studies of the aqueous root extract of Lecaniodiscus cupanioides. Nigerian Journal of Health and Biomedical Sciences, 3(1): 20-23. DOI: 10.4314/njhbs.v3i1.11501 Search in Google Scholar

Zhou, B., Huang, Y., Li, H., Sun, W., and Liu, J. (2016). Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporosis International, 27(1): 339-347. DOI: 10.1007/s00198-015-3365-x Search in Google Scholar